Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
Recruiting
Observational Study
Intensive Care Unit Syndrome
Intensive Care Neuropathy
Intensive Care (ICU) Myopathy
Acute Respiratory Distress Syndrome
Cardiac Failure
Respiratory Failure
Critical Illness Myopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Barts & The London NHS Trust · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Above the age of 18
* Adults with severe cardio-respiratory failure requiring ECMO.
* Adults who have had personal and professional consultees agree to enrol them in the trial.
Exclusion criteria:
* Previous Stroke
* Neuromuscular disease
* Malignancy
* Underlying neuromuscu…
Contacts